Ticagrelor with or without Aspirin in High-Risk Patients after PCI
0
Authors
Roxana Mehran
Roxana Mehran•Bernhard Witzenbichler•C. Gibson
Published
September 26, 2019
Abstract
Monotherapy with a P2Y12 inhibitor after a minimum period of dual antiplatelet therapy is an emerging approach to reduce the risk of bleeding after percutaneous coronary intervention (PCI).
